The india biosimilar market size was valued at USD 6,734.9 million in 2022 and is poised to grow at a significant CAGR of 27.6% during the forecast period 2023-29. The future of biosimilars requires significant research and development efforts. Indian companies are likely to invest more in R&D to improve their manufacturing processes, ensure high quality, and develop more complex biosimilar molecules.
Eliza Adalynn
1881bet
Pg88
C55
Nhà Cái Vaobet
Tv88
Koitoto Togel 4d
Go88
Fake Hub
6846fun.com